Molecular simulation study of CYP2B6 polymorphism with and without psoralen

被引:0
|
作者
Lu, Nan [1 ,2 ]
Meng, Fancui [3 ]
Xu, Weiren [3 ]
Tang, Lida [3 ]
Xu, Youjun [1 ,2 ]
机构
[1] Shenyang Pharmaceut Univ, Sch Pharmaceut Engn, Shenyang, Liaoning, Peoples R China
[2] Shenyang Pharmaceut Univ, Key Lab Struct Based Drug Design & Discovery, Shenyang, Liaoning, Peoples R China
[3] Tianjin Inst Pharmaceut Res, Tianjin Key Lab Mol Design & Drug Discovery, Tianjin, Peoples R China
关键词
CYP2B6; psoralen; molecular dynamics; molecular docking; mechanism-based inactivation; MECHANISM-BASED INACTIVATION; SINGLE NUCLEOTIDE POLYMORPHISM; CYTOCHROMES P450; FUNCTIONAL-CHARACTERIZATION; ALLELIC VARIANTS; STRUCTURAL BASIS; IN-SILICO; ACTIVATION; INHIBITION; EXPRESSION;
D O I
10.1080/08927022.2018.1513646
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
CYP2B6 is a polymorphic enzyme with a large number of variants which may lead to functional changes in enzyme activity and substrate selectivity. In this study, CYP2B6 and its three variants with and without psoralen, a mechanism-based inactivator, were investigated using molecular simulation method. The obtained docking orientation of psoralen was in agreement with previously identified site of metabolism. Stability analysis showed that the three variants displayed more flexibility than CYP2B6.1, and CYP2B6.34 was the most flexible one without psoralen binding. However, in the presence of psoralen, CYP2B6.34 became more rigidity. Tunnel analysis indicates that the bottleneck change of tunnels may be correlated to the increased or decreased activity of variants. Binding free energy analysis shows that van der Waals interaction dominates the binding of psoralen. CYP2B6.34 has the highest affinity to psoralen with lowest binding free energy. Ile114, Phe115 and heme contribute largely to the binding of psoralen with CYP2B6.6, while Phe206 and Leu363 play important roles for CYP2B6.1 and CYP2B6.4. These computational observations suggest that the increased activity of CYP2B6.4 and reduced activity of CYP2B6.6 may be due to changes in regional structures.
引用
收藏
页码:1402 / 1410
页数:9
相关论文
共 50 条
  • [41] Relevance of CYP2B6 and CYP2D6 genotypes to methadone pharmacokinetics and response in the OPAL study
    Victorri-Vigneau, Caroline
    Verstuyft, Celine
    Bouquie, Regis
    Laforgue, Edouard-Jules
    Hardouin, Jean-Benoit
    Leboucher, Juliette
    Le Geay, Bertrand
    Dano, Corine
    Challet-Bouju, Gaelle
    Grall-Bronnec, Marie
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 85 (07) : 1538 - 1543
  • [42] Examination of purported probes of human CYP2B6
    Ekins, S
    VandenBranden, M
    Ring, BJ
    Wrighton, SA
    [J]. PHARMACOGENETICS, 1997, 7 (03): : 165 - 179
  • [43] Metabolism of (-)-fenchone by CYP2A6 and CYP2B6 in human liver microsomes
    Miyazawa, M.
    Gyoubu, K.
    [J]. XENOBIOTICA, 2007, 37 (02) : 194 - 204
  • [44] The role of CYP2B6 in human xenobiotic metabolism
    Ekins, S
    Wrighton, SA
    [J]. DRUG METABOLISM REVIEWS, 1999, 31 (03) : 719 - 754
  • [45] Differences in Methadone Metabolism by CYP2B6 Variants
    Gadel, Sarah
    Friedel, Christina
    Kharasch, Evan D.
    [J]. DRUG METABOLISM AND DISPOSITION, 2015, 43 (07) : 994 - 1001
  • [46] The effects of CYP2B6 inactivators on the metabolism of ciprofol
    Lu, Ming
    Zhang, Xiaorui
    Li, Wenli
    Li, Xiangchen
    Li, Shan
    Yin, Xiaoyu
    Zhang, Zhiqing
    [J]. PLOS ONE, 2024, 19 (07):
  • [47] Hepatic CYP2B6 expression:: Gender and ethnic differences and relationship to CYP2B6 genotype and CAR (Constitutive Androstane Receptor) expression
    Lamba, V
    Lamba, J
    Yasuda, K
    Strom, S
    Davila, J
    Hancock, ML
    Fackenthal, JD
    Rogan, PK
    Ring, B
    Wrighton, SA
    Schuetz, EG
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 307 (03): : 906 - 922
  • [48] CYP2B6: Inching towards personalized medicine
    Gogtay, N. J.
    [J]. JOURNAL OF POSTGRADUATE MEDICINE, 2012, 58 (04) : 233 - 234
  • [49] Effects of CYP3A5, CYP2C19, and CYP2B6 on the clinical efficacy and adverse outcomes of sibutramine therapy: A crucial role for the CYP2B6*6 allele
    Hwang, In Cheol
    Park, Ji Young
    Ahn, Hong Yup
    Kim, Kyoung Kon
    Suh, Heuy Sun
    Ko, Ki Dong
    Kim, Kyoung-Ah
    [J]. CLINICA CHIMICA ACTA, 2014, 428 : 77 - 81
  • [50] Molecular modelling of CYP2B6, the human CYP2B isoform, by homology with the substrate-bound CYP102 crystal structure:: evaluation of CYP2B6 substrate characteristics, the cytochrome b5 binding site and comparisons with CYP2B1 and CYP2B4
    Lewis, DFV
    Lake, BG
    Dickins, M
    Eddershaw, PJ
    Tarbit, MH
    Goldfarb, PS
    [J]. XENOBIOTICA, 1999, 29 (04) : 361 - 393